July 23, 2024CorporateMicroVention Announces Release of CLinical EValuation of WEB™ 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured AneurysmsMicroVention is Also Celebrating the Five-Year Anniversary of its WEB™ Aneurysm Embolization System with more than 10,000 Units Sold in the United States
July 11, 2024FinancialNotice Regarding Disposal of Treasury Shares as Restricted Stock Remuneration (PDF 142.31 KB)
July 11, 2024FinancialNotice Concerning the Issuance of Stock Options (Share Warrants) (PDF 114.67 KB)
Top Management Message Message from top management to shareholders and investors. /investors/management/message Corporate Governance /about/governance Compliance /about/compliance Leadership Team /about/leadership Business Risks Major risks that may affect the business performance and financial position of the Terumo Group are described. /investors/management/risk IR Policy /investors/management/ir_policy Disclaimer /investors/disclaimer